Van K. Morris, Miguel Colon Donate, Jenny Seligmann, Atsuo Takashima, Dirk Arnold, Monika Dudzisz-Sledz, Jennifer Pulini, Chuan Tian, Thomas Benjamin Karasic, Aparna Raj Parikh. "INCA033890-303: A randomized, double-blind, phase 3 study of FOLFOX and bevacizumab with or without INCA33890 in the first-line treatment of metastatic microsatellite-stable colorectal cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps3683